Mindray's BeneVision N-Series is the first patient monitoring platform to integrate Edwards' FloTrac™ sensor technology to offer greater insights into advanced hemodynamic monitoring to manage ...
Jan. 31, 2006 -- A dual-chamber implantable cardioverter defibrillator has been released on the European market following approval by the European Commission (EC) last year; the EC has approved an ...
BRUSSELS, Belgium, March 22 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), a global leader in hemodynamic monitoring technologies, announced the European launch of its Edwards FloTrac(TM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback